Tarveda To Present At North American Neuroendocrine Tumor Society (NANETS) Symposium

WATERTOWN, Mass.--(BUSINESS WIRE)--Tarveda Therapeutics, Inc., a biopharmaceutical company discovering and developing Pentarins™ as a new class of targeted anti-cancer medicines, today announced that the company will present at the 2016 North American Neuroendocrine Tumor Society (NANETS) Symposium, September 30 – October 1, at the Jackson Lake Lodge, Grand Teton National Park, in Jackson, Wyoming.

Back to news